BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12872262)

  • 1. Novel intronic polymorphisms in the RET proto-oncogene and their association with Hirschsprung disease.
    Fitze G; Schierz M; Kuhlisch E; Schreiber M; Ziegler A; Roesner D; Schackert HK
    Hum Mutat; 2003 Aug; 22(2):177. PubMed ID: 12872262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR).
    Fitze G; Appelt H; König IR; Görgens H; Stein U; Walther W; Gossen M; Schreiber M; Ziegler A; Roesner D; Schackert HK
    Hum Mol Genet; 2003 Dec; 12(24):3207-14. PubMed ID: 14600022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Within-gene interaction between c.135 G/A genotypes and RET proto-oncogene germline mutations in HSCR families.
    Fitze G; Cramer J; Serra A; Schreiber M; Roesner D; Schackert HK
    Eur J Pediatr Surg; 2003 Jun; 13(3):152-7. PubMed ID: 12939698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease.
    Nishikawa M; Murakumo Y; Imai T; Kawai K; Nagaya M; Funahashi H; Nakao A; Takahashi M
    Eur J Hum Genet; 2003 May; 11(5):364-8. PubMed ID: 12734540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET 3'UTR polymorphisms and its protective role in Hirschsprung disease in southeastern Chinese.
    Pan ZW; Luo CF; Liu ZJ; Li JC
    J Pediatr Surg; 2012 Sep; 47(9):1699-705. PubMed ID: 22974609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma.
    Borrego S; Wright FA; Fernández RM; Williams N; López-Alonso M; Davuluri R; Antiñolo G; Eng C
    Am J Hum Genet; 2003 Jan; 72(1):88-100. PubMed ID: 12474140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RET C620S mutation causes multiple endocrine neoplasia type 2A (MEN2A) but not Hirschsprung disease (HSCR) in a family cosegregating both phenotypes.
    Fernández RM; Antiñolo G; Eng C; Borrego S
    Hum Mutat; 2003 Nov; 22(5):412-5. PubMed ID: 14517954
    [No Abstract]   [Full Text] [Related]  

  • 9. Specific polymorphisms in the RET proto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expression.
    Borrego S; Sáez ME; Ruiz A; Gimm O; López-Alonso M; Antiñolo G; Eng C
    J Med Genet; 1999 Oct; 36(10):771-4. PubMed ID: 10528857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation.
    Moore SW; Zaahl M
    J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
    McWhinney SR; Boru G; Binkley PK; Peczkowska M; Januszewicz AA; Neumann HP; Eng C
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4911-6. PubMed ID: 14557473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic differences in total colonic aganglionosis in Hirschsprung's disease.
    Moore SW; Zaahl M
    J Pediatr Surg; 2009 Oct; 44(10):1899-903. PubMed ID: 19853744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung disease.
    Borrego S; Ruiz A; Saez ME; Gimm O; Gao X; López-Alonso M; Hernández A; Wright FA; Antiñolo G; Eng C
    J Med Genet; 2000 Aug; 37(8):572-8. PubMed ID: 10922382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.
    Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A
    Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.
    Angrist M; Bolk S; Thiel B; Puffenberger EG; Hofstra RM; Buys CH; Cass DT; Chakravarti A
    Hum Mol Genet; 1995 May; 4(5):821-30. PubMed ID: 7633441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localizing a putative mutation as the major contributor to the development of sporadic Hirschsprung disease to the RET genomic sequence between the promoter region and exon 2.
    Burzynski GM; Nolte IM; Osinga J; Ceccherini I; Twigt B; Maas S; Brooks A; Verheij J; Plaza Menacho I; Buys CH; Hofstra RM
    Eur J Hum Genet; 2004 Aug; 12(8):604-12. PubMed ID: 15138456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.
    Wiench M; Włoch J; Wygoda Z; Gubała E; Oczko M; Pawlaczek A; Kula D; Lange D; Jarzab B
    Cancer Detect Prev; 2004; 28(4):231-6. PubMed ID: 15350625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele dosage-dependent penetrance of RET proto-oncogene in an Israeli-Arab inbred family segregating Hirschsprung disease.
    Basel-Vanagaite L; Pelet A; Steiner Z; Munnich A; Rozenbach Y; Shohat M; Lyonnet S
    Eur J Hum Genet; 2007 Feb; 15(2):242-5. PubMed ID: 17091122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.